ABB Labs Adds Avulux Migraine & Light Sensitivity Lenses to Extensive Portfolio of Lens Designs
Avulux lenses empower people living with migraine and light sensitivity to better manage everyday light exposure
Coral Springs, Fla. (September 3, 2025): ABB Optical Group announced today that ABB Labs has added Avulux Migraine and Light Sensitivity lenses to its extensive portfolio of lens designs. Avulux is the only clinically proven lens that precisely filters light to help people living with migraine and light sensitivity.
“ABB is uniquely positioned to serve private practices with the independence that ensures solutions are aligned with the best interest of eye care professionals," said President of ABB Optical Group James Gilchrist. "We are excited to deepen our relationship with PECAA, and we look forward to delivering greater value to PECAA Max members through a comprehensive suite of services that provide enhanced efficiency, expanded choices, and increased value from one trusted source."
“ABB is committed to offering our eye care provider customers the highest quality and most innovative lenses,” said James Gilchrist, President of ABB Optical Group. “We continue to expand our offerings so ECPs can differentiate their practice and provide their patients with the widest range of solutions from a single, trusted source. For individuals struggling with light sensitivity and migraine, we’re excited about the difference this can make for patients.”
Avulux lenses incorporate a multi-band precision optical filter that works by filtering up to 97% of harmful blue, amber, red light while allowing in soothing green light. Additionally, the Avulux lens is the only lens that has been clinically proven for people living with migraine and light sensitivity. In a 2020 double blind, randomized, placebo-controlled study conducted by an independent clinical research organization, the Avulux lens achieved both clinical and statistical significance when compared to a clear placebo lens. For more information about Avulux, visit ecp.avulux.com.
“We are thrilled to welcome ABB Labs into our growing network of labs as a center of excellence. Together, we can bring Avulux lenses to more people living with migraine and light sensitivity,” said Dr. Charles Posternack, President and CEO of Avulux. “ABB’s reputation for quality and service makes them an ideal partner as we expand access to our innovative light management solution.”
ABB Labs have the industry’s best service and quality of any national lab network, according to the results from a recent independent study*. ABB Labs customers had a satisfaction rating of 92% with over 98% of lab orders meeting customer quality expectations. Additionally, more customers planned on continuing to do business with ABB than any other lab; 9 out of 10 customers put their trust in ABB Labs and said they would remain an ABB Labs customer in 12 months.
Posternack and Gilchrist both shared their excitement about bringing together Avulux’s one-of-a-kind product technology and ABB’s high quality lab service to benefit ECPs. “Together we can help many more patients experience the life changing benefits of better vision, and migraine-free days.”
For information on how to begin offering Avulux through ABB, visit ecp.avulux.com/abb.
*Data Source: According to an independent study of 307 eyecare professionals conducted by Emergent Research. Data on file.
About ABB Optical Group
ABB Optical Group is the largest independent provider of optical products, services, and business solutions in the eye care industry committed to helping provide better vision for patients. ABB operates through three business pillars: ABB Contact Lens, ABB Labs, and ABB Business Solutions.
ABB is focused on the future of eye care professionals and helping them succeed by making practices more efficient through access, choice and consultation and the single source convenience so they can focus on what matters most. Visit abboptical.com for more information.
About Avulux
Actively supporting people living with migraine and light sensitivity is central to everything we do – it’s in our DNA. We are inspired by their stories and motivated by their courage. By delivering clinically-proven, best-in-class therapeutic lens technology, our ambition is to help them reclaim life on their terms.
Our reward? The hundreds of stories about how Avulux has helped them to love their life to the fullest.
For more information about Avulux, visit ecp.avulux.com.
Media Contacts:
For further media inquiries, please contact Sharon Martin at smartin@abboptical.com.
